Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 559798Generated: October 26, 2026

3-Methyl-5-(tributylstannyl)isoxazole → 6-Methyl-5-(3-methylisoxazol-5-yl)-N-[4-(methylsulfonyl)benzyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide

https://huagongshe.com/reaction/559798

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-Methyl-5-(tributylstannyl)isoxazoleHCID 2763255—
Reactant5-Iodo-6-methyl-N-[4-(methylsulfonyl)benzyl]-2-oxo-1-[3-(trifluoro-methyl)phenyl]1,2-dihydropyridine-3-carboxamideHCID 11519933—
CatalystHCID 178418397HCID 178418397—
Solvent1,2-DimethoxyethaneHCID 8071—
Product6-Methyl-5-(3-methylisoxazol-5-yl)-N-[4-(methylsulfonyl)benzyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamideHCID 66725310—

Reaction Steps

The title compound was synthesized in the same way as Example 29 but starting from 5-iodo-6-methyl-N-[4-(methylsulfonyl)benzyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide (50 mg, 0.085 mmol), tetrakis(triphenylphosphine)palladium (5 mg, 0.0043 mmol) and 3-methyl-5-(tributylstannyl)isoxazole [synthesized as described in Tetrahedron, 47, 28, 5111, 1991] (63 mg, 0.169 mmol) in DME (0.85 ml). Yield: 15 mg, 0.033 mmol (39%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08063073B2
Source datasetuspto-grants-2011_11
ORD IDord-a86724ac324a49d0a516b2fc2c8f5843
Source noteuspto-grants-2011_11